AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Superinvestors holding ABCL, Q2 2026
No superinvestor reported holding ABCL in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ABCL each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2024
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q3 2023
1 superinvestor holding at quarter end
- Sold out
- Maverick Capital
Q2 2023
2 superinvestors holding at quarter end
- Reduced
- Maverick Capital (−20.8%)
Q1 2023
2 superinvestors holding at quarter end
- Added
- Maverick Capital (+119.6%)
Q4 2022
2 superinvestors holding at quarter end
- Added
- Maverick Capital (+23.1%)
Q3 2022
2 superinvestors holding at quarter end
Q3 2021
1 superinvestor holding at quarter end
Q2 2021
0 superinvestors holding at quarter end